A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

NCT02590133 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

328

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: Recombinant Human Endostatin Injection (Endostar)
DRUG: Fluorouracil (5-Fu)
DRUG: Nedaplatin

Sponsor

Yun-fei Xia